• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3T下APTw CEST MRI在人脑肿瘤患者常规临床评估中的价值

The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T.

作者信息

Lingl Julia P, Wunderlich Arthur, Goerke Steffen, Paech Daniel, Ladd Mark E, Liebig Patrick, Pala Andrej, Kim Soung Yung, Braun Michael, Schmitz Bernd L, Beer Meinrad, Rosskopf Johannes

机构信息

Department of Radiology, Ulm University, Albert-Einstein-Allee 23, 89081 Ulm, Germany.

German Cancer Research Center (DKFZ), Department of Medical Physics in Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

出版信息

Diagnostics (Basel). 2022 Feb 14;12(2):490. doi: 10.3390/diagnostics12020490.

DOI:10.3390/diagnostics12020490
PMID:35204583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8871436/
Abstract

BACKGROUND

With fast-growing evidence in literature for clinical applications of chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI), this prospective study aimed at applying amide proton transfer-weighted (APTw) CEST imaging in a clinical setting to assess its diagnostic potential in differentiation of intracranial tumors at 3 tesla (T).

METHODS

Using the asymmetry magnetization transfer ratio (MTRasym) analysis, CEST signals were quantitatively investigated in the tumor areas and in a similar sized region of the normal-appearing white matter (NAWM) on the contralateral hemisphere of 27 patients with intracranial tumors. Area under curve (AUC) analyses were used and results were compared to perfusion-weighted imaging (PWI).

RESULTS

Using APTw CEST, contrast-enhancing tumor areas showed significantly higher APTw CEST metrics than contralateral NAWM (AUC = 0.82; < 0.01). In subgroup analyses of each tumor entity vs. NAWM, statistically significant effects were yielded for glioblastomas (AUC = 0.96; < 0.01) and for meningiomas (AUC = 1.0; < 0.01) but not for lymphomas as well as metastases ( > 0.05). PWI showed results comparable to APTw CEST in glioblastoma ( < 0.01).

CONCLUSIONS

This prospective study confirmed the high diagnostic potential of APTw CEST imaging in a routine clinical setting to differentiate brain tumors.

摘要

背景

随着化学交换饱和转移(CEST)磁共振成像(MRI)临床应用的文献证据迅速增加,这项前瞻性研究旨在将酰胺质子转移加权(APTw)CEST成像应用于临床环境,以评估其在3特斯拉(T)下鉴别颅内肿瘤的诊断潜力。

方法

使用不对称磁化转移率(MTRasym)分析,对27例颅内肿瘤患者肿瘤区域及对侧半球正常白质(NAWM)中大小相似区域的CEST信号进行定量研究。采用曲线下面积(AUC)分析,并将结果与灌注加权成像(PWI)进行比较。

结果

使用APTw CEST,增强肿瘤区域的APTw CEST指标显著高于对侧NAWM(AUC = 0.82;<0.01)。在各肿瘤实体与NAWM的亚组分析中,胶质母细胞瘤(AUC = 0.96;<0.01)和脑膜瘤(AUC = 1.0;<0.01)有统计学显著效应,而淋巴瘤和转移瘤则无(>0.05)。PWI在胶质母细胞瘤中的结果与APTw CEST相当(<0.01)。

结论

这项前瞻性研究证实了APTw CEST成像在常规临床环境中鉴别脑肿瘤的高诊断潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a15/8871436/3bf3f0e98364/diagnostics-12-00490-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a15/8871436/bf5184b1db5e/diagnostics-12-00490-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a15/8871436/3bf3f0e98364/diagnostics-12-00490-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a15/8871436/bf5184b1db5e/diagnostics-12-00490-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a15/8871436/3bf3f0e98364/diagnostics-12-00490-g002.jpg

相似文献

1
The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T.3T下APTw CEST MRI在人脑肿瘤患者常规临床评估中的价值
Diagnostics (Basel). 2022 Feb 14;12(2):490. doi: 10.3390/diagnostics12020490.
2
Assessment of Early Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer Using Amide Proton Transfer-weighted Chemical Exchange Saturation Transfer MRI: A Pilot Study.使用酰胺质子转移加权化学交换饱和转移磁共振成像评估三阴性乳腺癌新辅助全身治疗的早期反应:一项初步研究。
Radiol Imaging Cancer. 2021 Sep;3(5):e200155. doi: 10.1148/rycan.2021200155.
3
Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI.酰胺质子转移(APT)和磁化转移(MT)在预测鼻咽癌放化疗后短期疗效中的作用:三维化学交换饱和传递(CEST)MRI 的可行性研究。
Cancer Imaging. 2023 Sep 1;23(1):80. doi: 10.1186/s40644-023-00602-6.
4
Generalization of quasi-steady-state reconstruction to CEST MRI with two-tiered RF saturation and gradient-echo readout-Synergistic nuclear Overhauser enhancement contribution to brain tumor amide proton transfer-weighted MRI.具有双层射频饱和和梯度回波读出的CEST MRI准稳态重建的推广——协同核Overhauser增强对脑肿瘤酰胺质子转移加权MRI的贡献
Magn Reson Med. 2023 May;89(5):2014-2023. doi: 10.1002/mrm.29570. Epub 2022 Dec 29.
5
Chemical exchange saturation transfer (CEST) MR technique for in-vivo liver imaging at 3.0 tesla.用于3.0特斯拉体内肝脏成像的化学交换饱和转移(CEST)磁共振技术。
Eur Radiol. 2016 Jun;26(6):1792-800. doi: 10.1007/s00330-015-3972-0. Epub 2015 Sep 3.
6
Rapid three-dimensional steady-state chemical exchange saturation transfer magnetic resonance imaging.快速三维稳态化学交换饱和传递磁共振成像。
Magn Reson Med. 2021 Mar;85(3):1209-1221. doi: 10.1002/mrm.28487. Epub 2020 Aug 27.
7
Improved chemical exchange saturation transfer imaging with real-time frequency drift correction.实时频率漂移校正的化学交换饱和转移成像的改进。
Magn Reson Med. 2019 May;81(5):2915-2923. doi: 10.1002/mrm.27663. Epub 2019 Jan 30.
8
Fluid suppression in amide proton transfer-weighted (APTw) CEST imaging: New theoretical insights and clinical benefits.酰胺质子转移加权(APTw)化学交换饱和转移(CEST)成像中的流体抑制:新的理论见解和临床获益。
Magn Reson Med. 2024 Apr;91(4):1354-1367. doi: 10.1002/mrm.29915. Epub 2023 Dec 10.
9
Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.在3特斯拉磁场下,使用基于内源性蛋白质的酰胺质子转移磁共振成像对原发性中枢神经系统淋巴瘤和高级别胶质瘤进行分子磁共振成像鉴别
Eur Radiol. 2016 Jan;26(1):64-71. doi: 10.1007/s00330-015-3805-1. Epub 2015 Apr 30.
10
Chemical exchange saturation transfer imaging in hepatic encephalopathy.化学交换饱和传递成像在肝性脑病中的应用。
Neuroimage Clin. 2019;22:101743. doi: 10.1016/j.nicl.2019.101743. Epub 2019 Mar 4.

引用本文的文献

1
Motion and magnetic field inhomogeneity correction techniques for chemical exchange saturation transfer (CEST) MRI: A contemporary review.化学交换饱和传递(CEST)MRI 的运动和磁场不均匀性校正技术:当代综述。
NMR Biomed. 2025 Jan;38(1):e5294. doi: 10.1002/nbm.5294. Epub 2024 Nov 12.
2
Performance of amide proton transfer imaging to differentiate true progression from therapy-related changes in gliomas and metastases.酰胺质子转移成像在鉴别胶质瘤和转移瘤的真性进展与治疗相关变化中的应用。
Eur Radiol. 2025 Feb;35(2):580-591. doi: 10.1007/s00330-024-11004-y. Epub 2024 Aug 12.
3
Deep Learning-Based Denoising of CEST MR Data: A Feasibility Study on Applying Synthetic Phantoms in Medical Imaging.

本文引用的文献

1
Pulseq-CEST: Towards multi-site multi-vendor compatibility and reproducibility of CEST experiments using an open-source sequence standard.Pulseq-CEST:使用开放源代码序列标准实现 CEST 实验的多站点、多供应商兼容性和可重现性。
Magn Reson Med. 2021 Oct;86(4):1845-1858. doi: 10.1002/mrm.28825. Epub 2021 May 7.
2
Clinical routine acquisition protocol for 3D relaxation-compensated APT and rNOE CEST-MRI of the human brain at 3T.临床常规获取协议 3T 下人类大脑的 3D 弛豫补偿 APT 和 rNOE CEST-MRI
Magn Reson Med. 2021 Jul;86(1):393-404. doi: 10.1002/mrm.28699. Epub 2021 Feb 14.
3
Identification of Early Response to Anti-Angiogenic Therapy in Recurrent Glioblastoma: Amide Proton Transfer-weighted and Perfusion-weighted MRI compared with Diffusion-weighted MRI.
基于深度学习的CEST磁共振数据去噪:关于在医学成像中应用合成体模的可行性研究。
Diagnostics (Basel). 2023 Oct 27;13(21):3326. doi: 10.3390/diagnostics13213326.
4
Chemical Exchange Saturation Transfer MRI: What Neuro-Oncology Clinicians Need To Know.化学交换饱和转移磁共振成像:神经肿瘤临床医生需要了解的知识。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231208613. doi: 10.1177/15330338231208613.
5
Advances in the Radiological Evaluation of and Theranostics for Glioblastoma.胶质母细胞瘤的放射学评估与诊疗一体化的进展
Cancers (Basel). 2023 Aug 18;15(16):4162. doi: 10.3390/cancers15164162.
6
Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma.三维酰胺质子转移加权成像用于鉴别胶质母细胞瘤、异柠檬酸脱氢酶野生型和原发性中枢神经系统淋巴瘤
Cancers (Basel). 2023 Feb 2;15(3):952. doi: 10.3390/cancers15030952.
7
Amide proton transfer MRI differentiates between progressive multifocal leukoencephalopathy and malignant brain tumors: a pilot study.酰胺质子转移 MRI 可区分进行性多灶性白质脑病和恶性脑肿瘤:一项初步研究。
BMC Med Imaging. 2022 Dec 26;22(1):227. doi: 10.1186/s12880-022-00959-3.
8
Quantitative Chemical Exchange Saturation Transfer Imaging of Amide Proton Transfer Differentiates between Cerebellopontine Angle Schwannoma and Meningioma: Preliminary Results.酰胺质子转移定量化学交换饱和转移成像可区分桥小脑角神经鞘瘤和脑膜瘤:初步结果。
Int J Mol Sci. 2022 Sep 5;23(17):10187. doi: 10.3390/ijms231710187.
复发性脑胶质瘤抗血管生成治疗早期反应的识别:酰胺质子转移加权和灌注加权 MRI 与弥散加权 MRI 的比较。
Radiology. 2020 May;295(2):397-406. doi: 10.1148/radiol.2020191376. Epub 2020 Mar 10.
4
Chemical exchange saturation transfer magnetic resonance imaging and its main and potential applications in pre-clinical and clinical studies.化学交换饱和转移磁共振成像及其在临床前和临床研究中的主要应用与潜在应用。
Quant Imaging Med Surg. 2019 Oct;9(10):1747-1766. doi: 10.21037/qims.2019.10.03.
5
Advanced Magnetic Resonance Imaging Techniques in Management of Brain Metastases.脑转移瘤治疗中的先进磁共振成像技术
Front Oncol. 2019 Jun 4;9:440. doi: 10.3389/fonc.2019.00440. eCollection 2019.
6
Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?酰胺质子转移加权成像能否区分脑膜瘤的肿瘤级别并预测 Ki-67 增殖状态?
Eur Radiol. 2019 Oct;29(10):5298-5306. doi: 10.1007/s00330-019-06115-w. Epub 2019 Mar 18.
7
Early response assessment of glioma patients to definitive chemoradiotherapy using chemical exchange saturation transfer imaging at 7 T.7T 下化学交换饱和转移成像在脑胶质瘤患者根治性放化疗早期疗效评估中的应用
J Magn Reson Imaging. 2019 Oct;50(4):1268-1277. doi: 10.1002/jmri.26702. Epub 2019 Mar 12.
8
Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.弛豫增强酰胺质子转移(APT)MRI 信号强度与高级别胶质瘤患者的生存和进展相关。
Eur Radiol. 2019 Sep;29(9):4957-4967. doi: 10.1007/s00330-019-06066-2. Epub 2019 Feb 26.
9
pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma.pH 加权胺化学交换饱和传递 EPI(CEST-EPI)作为复发性胶质母细胞瘤贝伐单抗治疗失败的潜在早期生物标志物。
J Neurooncol. 2019 May;142(3):587-595. doi: 10.1007/s11060-019-03132-z. Epub 2019 Feb 26.
10
APT-weighted MRI: Techniques, current neuro applications, and challenging issues.基于适配体的磁共振成像:技术、当前神经学应用及挑战性问题。
J Magn Reson Imaging. 2019 Aug;50(2):347-364. doi: 10.1002/jmri.26645. Epub 2019 Jan 20.